MYC Deregulation in Primary Human Cancers
Open Access
Abstract
MYC regulates a complex biological program by transcriptionally activating and repressing its numerous target genes. As such, MYC is a master regulator of many processes, including cell cycle entry, ribosome biogenesis, and metabolism. In cancer, the activity of the MYC transcriptional network is frequently deregulated, contributing to the initiation and maintenance of disease. Deregulation often leads to constitutive overexpression of MYC, which can be achieved through gross genetic abnormalities, including copy number alterations, chromosomal translocations, increased enhancer activity, or through aberrant signal transduction leading to increased MYC transcription or increased MYC mRNA and protein stability. Herein, we summarize the frequency and modes of MYC deregulation and describe both well-established and more recent findings in a variety of cancer types. Notably, these studies have highlighted that with an increased appreciation for the basic mechanisms deregulating MYC in cancer, new therapeutic vulnerabilities can be discovered and potentially exploited for the inhibition of this potent oncogene in cancer.Keywords
This publication has 252 references indexed in Scilit:
- Novel mutations target distinct subgroups of medulloblastomaNature, 2012
- Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYCCancer Cell, 2012
- A Mouse Model of the Most Aggressive Subgroup of Human MedulloblastomaCancer Cell, 2012
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-MycCell, 2011
- Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myelomaLeukemia, 2011
- c-Myc Regulates Transcriptional Pause ReleaseCell, 2010
- Distinct Thresholds Govern Myc's Biological Output In VivoCancer Cell, 2008
- Mutations of the BRAF gene in human cancerNature, 2002
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- Phosphatidylinositol-3-OH kinase direct target of RasNature, 1994